Other authors reported that diffuse gastric carcinomas account for 5–6.2% of all ERBB2-amplified carcinomas (Tanner et al, 2005; Park et al, 2006; Kim et al, 2007), which is corroborated by our findings. This evidence concerns the gene ERBB2 and carcinoma.